The Effect of Cancer Pain Management Protocol on Hospitalized Cancer Patients: A Pilot Study

Phase 4

Completed

• Conditions: Cancers, Pain
• Interventions: Drug: Cancer pain management

• Registration Number: NCT01043068
• Lead Sponsor: National Cancer Center, Korea

Brief Summary

The purpose of this study was to prospectively evaluate the effect of cancer pain management protocol on hospitalized cancer patients.

Detailed Description

Not available

Study Timeline

• Study Start: 2010-01
• Study First Submitted: 2010-01-05
• Study First Submitted QC: 2010-01-05
• Study First Posted: 2010-01-06
• Primary Completion: 2010-12
• Study Completion: 2010-12
• Status Verified: 2012-04
• Last Update Submitted: 2012-04-25
• Last Update Posted: 2012-04-27

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 25

Inclusion Criteria

• Hospitalized patient with the somatic and/or visceral pain having an untreated intensity greater than 3 on a 10 cm visual analog scale (VAS; 0 = no pain, 10 = unbearable pain)over the week prior to enrollment
• A minimum age of 18 years

Exclusion Criteria

• Opioid intolerance
• No longer treatment for their underlying disease.
• Intracerebral primary or metastatic lesion
• Impaired sensory or cognitive function
• Pregnant or lactating woman
• Women of child bearing potential not using a contraceptive method
• Sexually active fertile men not using effective birth control during medication of study drug and up to 6 months after completion of study drug if their partners are women of child-bearing potential
• Any patients judged by the investigator to be unfit to participate in the study

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Arm && Interventions

Group	Intervention	Description
Pain control	Cancer pain management	Interventions based on published pain guideline. The interventions consisted of the following: (1) nursing pain assessment of current pain, worst pain, pain relief, and acceptability of pain; (2) feedback to guide analgesic prescribing by physician.

Primary Outcome Measures

Name	Time	Method
Reduction in pain scores	Jan 2010 - October 2010

Trial Locations

Locations (1)

National Cancer Center; 🇰🇷 Goyang, Gyeonggi-do, Korea, Republic of